asx announcement - 6 december 2013 for personal use only · 2020. 5. 28. · apex healthcare berhad...

52
ASX Announcement - 6 December 2013 Annual General Meeting - 6 December 2013 Attached is the Chairman’s Address to be presented at the 2013 Annual General Meeting of the Company later today. I.D. Bloodworth Company Secretary For personal use only

Upload: others

Post on 24-Sep-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

ASX Announcement - 6 December 2013 Annual General Meeting - 6 December 2013 Attached is the Chairman’s Address to be presented at the 2013 Annual General Meeting of the Company later today.

I.D. Bloodworth Company Secretary

For

per

sona

l use

onl

y

Page 2: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

1

Good afternoon Ladies and Gentlemen, my name is Robert Millner, I am the Chairman

of Washington H. Soul Pattinson and I would like to welcome you to the 111th Annual

General Meeting of the Company.

I hope you found the video and the displays by Group companies interesting and

informative.

I would like to clarify the statement in the video regarding BKI Investment Company and

brokerage charges.

Brokerage is payable by investors on the purchase and sale of BKI shares.

Brokerage is not payable by existing BKI shareholders under its dividend reinvestment

plan, share purchase plans or entitlement offers.

I am advised that a quorum is present and therefore declare the Meeting open.

Before we proceed I would like to introduce to you the other members of the board:-

Mr. Peter Robinson, is our executive director

Mr. David Fairfull,

Mr. Michael Hawker,

Mr. Tom Millner,

Mr. Robert Westphal, and

Mr. David Wills are all non executive directors.

Ms. Melinda Roderick is our Chief Financial Officer, and

Mr. Ian Bloodworth is the Company Secretary

Mr. Joe Shannon of Moore Stephens Sydney, the Company’s Auditors, is also present.

1

For

per

sona

l use

onl

y

Page 3: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

2

I propose that the Notice of Meeting dated 25th October 2013, which was mailed to all

registered shareholders of the Company be taken as read.

I will now present my address, after which shareholders will have the opportunity to ask

questions.

We will then conduct the formal business of the meeting.

2

For

per

sona

l use

onl

y

Page 4: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Washington H. Soul Pattinson and Company Limited was listed on the ASX in 1903

making it the second oldest listed company on the ASX.

Since listing WHSP has never missed paying a dividend and has never raised capital.

Today WHSP has a market capitalisation of approximately $3.5 billion and 10,500

shareholders.

3

For

per

sona

l use

onl

y

Page 5: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

WHSP is a diversified investment company with a range of investments – both listed

and unlisted.

On this slide are a number of the major investments of the group.

In the left hand column are the companies where we have a controlling shareholding

and are therefore consolidated in our accounts. New Hope is the only listed company

which is controlled.

The middle column are companies deemed to be associates because of large

shareholdings which are not controlling stakes.

The column on the right shows some of the Group’s other significant investments.

Many of the listed companies you see on this slide were once private companies backed

by WHSP and have since been floated or merged with other companies on the ASX.

WHSP has a strong track record of nurturing companies through all phases of growth.

4

For

per

sona

l use

onl

y

Page 6: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Group Performance

Consolidated Results

Year Ended 31 July 2013

The regular profit after tax attributable to shareholders for the year ended 31 July 2013

was $160.7 million, marginally lower than the $161.6 million for 2012.

The result was driven by;

Higher contributions from Brickworks and TPG Telecom;

An improved result for CopperChem;

A lower contribution from New Hope; and

Last year’s result included a $13 million special dividend from Exco.

5

For

per

sona

l use

onl

y

Page 7: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Group Performance

Consolidated Results

Year Ended 31 July 2013

The total profit of the Group was $105.4 million, a decrease of $37.6 million compared

with 2012.

The net loss on non-regular items was $55.2 million for the year, an increase of $36.6

million.

Impairments by New Hope of its investments accounted for $30.7 million of the non-

regular loss.

6

For

per

sona

l use

onl

y

Page 8: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Group Performance

Profit After Tax attributable to Members

This chart shows the groups performance over the last 10 years.

It has been split into Regular Profit (which is before non-regular items) and Total Profit

(which includes non-regular items).

The light blue bars represent Regular Profits and it is these results that the Directors

consider when declaring ordinary dividends.

The variability of the Group’s profits including non-regular items is evident.

7

For

per

sona

l use

onl

y

Page 9: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Dividends

The Final Dividend declared for 2013 was 28 cents per share, which is up 3.7% on last

years final dividend.

The dividend will be fully franked and is payable on 9 December 2013.

This brings Total Dividends for the year to 46 cents per share an increase of 4.5%.

The Company receives dividends from its investments and interest from funds on

deposit.

This year total dividends paid represent 76.6% of the ordinary dividends and interest

received.

8

For

per

sona

l use

onl

y

Page 10: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

WHSP (Parent Company)

Listed Equity Investments (excluding controlled entities & associates)

Excluding controlled entities and associates, the market value of the Company’s listed

equities was $521.2 million at 31 July 2013.

After adjusting for Exco Resources, which is now a controlled entity, this represents an

increase of 20% for the year.

$6.4 million was invested during the year, proceeds from disposals totalled $9.3 million

and capital returns of $4.3 million were received.

Ordinary dividend and distribution income was $20.8 million an increase of 2.3% over

2012.

9

For

per

sona

l use

onl

y

Page 11: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

WHSP (Parent Company)

Listed Equity Investments (including controlled entities & associates)

Including controlled entities and associates, the market value of the Company’s listed

equities portfolio was $4.2 billion as at 31 July 2013.

After adjusting for the investment in Exco, which was delisted during the period, this

represents an increase of 13.1% since July 2012.

I will discuss the takeover of Exco shortly.

10

For

per

sona

l use

onl

y

Page 12: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Controlled Entities

New Hope Corporation Limited – 59.7%

Year Ended 31 July 2013

New Hope’s net profit after tax before non-recurring items was $125 million, down 27%

on last year.

Due to the weak market conditions prevailing at year end, New Hope impaired its

investments in Dart Energy, Westside Corporation and the Quantex Group. The total

impairment was $51.4 million after tax.

The net profit after tax including non-recurring items was $74.1 million, 55.6% lower

than last year.

11

For

per

sona

l use

onl

y

Page 13: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Controlled Entities

New Hope Corporation Limited – 59.7%

Year Ended 31 July 2013

The result from operations was impacted by:

Lower export coal prices;

A higher USD exchange rate for the majority of the year;

Slightly lower production due to lost sales from a 3 week rail outage in early 2013; and

Tapering production from Oakleigh and Jeebropilly due to market conditions.

12

For

per

sona

l use

onl

y

Page 14: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Controlled Entities

New Hope Corporation Limited – 59.7%

Year Ended 31 July 2013

New Hope has declared a final dividend of 5 cents per share and a special dividend of

5 cents per share.

Both of these dividends are fully franked.

Including this years special dividend New Hope has returned a total of $1.3 billion to

shareholders in the form of fully franked special dividends since listing in 2003.

NHC contributed $44.2 million to Group Profit.

13

For

per

sona

l use

onl

y

Page 15: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Controlled Entities

CopperChem Limited / Exco Resources Limited – 100%

Year Ended 31 July 2013

CopperChem is a producer of copper sulphide and copper concentrate. Its operations are

based in Cloncurry, North West Queensland.

In May this year the remaining shares in CopperChem were acquired making it a wholly

owned Group Company.

2013 was a turn-around year for CopperChem.

It implemented a new operating strategy and built new management and operating

teams.

As part of this strategy, CopperChem transitioned its workforce from Fly-In-Fly-Out to

residential.

These initiatives have reduced total costs by 12.5% despite a doubling of the production

rate.

This equates to a 59.7% reduction in processing costs per tonne.

14

For

per

sona

l use

onl

y

Page 16: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Controlled Entities

CopperChem Limited / Exco Resources Limited – 100%

Operationally, CopperChem initiated mining from two additional open cut mines whilst

the copper concentrator throughput was increased from its 60 tonnes per hour design

capacity to 100 tonnes per hour without significant capital expenditure.

Production of copper sulphide from the heap leach operation was affected by a severe

shortage of water due to drought conditions.

Despite this and a challenging ore structure CopperChem reduced its second half loss to

$4.9 million compared to a loss of $17.1 million for the first half.

CopperChem contributed a net loss of $20.9 million to the Group.

15

For

per

sona

l use

onl

y

Page 17: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Controlled Entities

CopperChem Limited / Exco Resources Limited – 100%

Exco

In November 2012 Exco became a subsidiary of WHSP and is now 100% owned.

WHSP invested $83.2 million in Exco during the year bringing the total amount invested

to $101.9 million.

Exco was debt free and held cash reserves in excess of $45 million when the takeover

was completed.

In addition, WHSP received a $13.0 million special dividend from Exco during the 2012

financial year.

Exco contributed $0.9 million to Group Profit for the year.

16

For

per

sona

l use

onl

y

Page 18: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Controlled Entities

Pitt Capital Partners Limited – 100%

Year Ended 31 July 2013

PCP is a corporate advisory firm specialising in mergers, strategic advice, equity capital

markets, private equity, restructuring and debt advisory work.

During the year PCP increased its holding in Pitt Street Real Estate Partners to 75%

making it a subsidiary.

Pitt Street Real Estate specialises in identifying and managing investments in the real

estate sector which provide above average risk adjusted returns.

Pitt Street Real Estate is the manager of the Australian Logistics Property Fund which is

100% owned by WHSP.

For the year ended 31 July 2013 PCP contributed $1.5 million to Group Profit.

17

For

per

sona

l use

onl

y

Page 19: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Controlled Entities

Australian Logistics Property Fund – 100%

Year Ended 31 July 2013

The ALPF was established in February 2013 to develop and lease distribution centres to

major tenants across Australia.

Construction has commenced on two distribution centres for the Super Retail Group.

One at Erskine Park in NSW and the other at Brendale in Queensland.

As at 31 July 2013 the Erskine Park project was 45% complete and

earth works were underway at Brendale.

WHSP had invested $47 million in the ALPF at 31 July 2013.

I will provide an update on these projects later in the presentation.

18

For

per

sona

l use

onl

y

Page 20: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Associated Entities

Ampcontrol – 43.3%

Year Ended 30 June 2013

Ampcontrol is a leading international supplier of electrical and electronic products

providing products and services to the mining sector, in particular for underground coal

mining.

(Amcontrol has operations across Australia and overseas including; Hong Kong, China,

New Zealand, South Africa, Botswana, Russia, the USA and the UK.)

Revenues for the year ended 30 June 2013 were $293.3 million whilst EBITDA was

$33.1 million.

Ampcontrol contributed a Net Profit of $6.9 million to the Group.

19

For

per

sona

l use

onl

y

Page 21: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Associated Entities

Apex Healthcare Berhad – 30.3%

Half Year Ended 30 June 2013

Apex Healthcare Berhad is a manufacturer, distributor and retailer of pharmaceutical and

healthcare products.

(It has operations in Malaysia, Singapore, Indonesia and Vietnam).

The following results for the 6 months ended 30 June 2013 have been restated in

Australian dollars.

Apex generated revenue of $68.3 million, an increase of 7.8% over the previous

corresponding period.

Net profit after tax was $5.1 million, an increase of 14.1%.

For the 12 months to 30 June 2013, Apex contributed $2.9 million to Group Profit.

20

For

per

sona

l use

onl

y

Page 22: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Associated Entities

BKI Investment Company Limited - 13.0%

Year Ended 30 June 2013

For the year ended 30 June 2013 BKI’s Net Operating Result (before special dividend

income) increased by 8% to $29.9 million.

BKI’s Share Price Performance (including the reinvestment of dividends) for the year

ended 30 June 2013 was 29.4%, outperforming the S&P/ASX 300 Accumulation Index

over the same period by 7.5%.

Total dividends for the year were up 11.7% to 7.15 cents per share, including a special

dividend of 0.5 cents per share which was paid in the first half.

BKI contributed a net profit of $4.4 million to the Group.

21

For

per

sona

l use

onl

y

Page 23: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Associated Entities

Brickworks Limited – 44.4%

Year Ended 31 July 2013

Brickworks Normalised Profit After Tax for the year ended 31 July 2013 was $100

million, an increase of 26.9% over last year. Total Profit After Tax was $85.2 million, an

increase of 96.7%. (these results include the equity accounted contribution from WHSP).

Brickworks’ has declared a Final Dividend of 27 cents per share fully franked,

unchanged from last year.

Brickworks contributed $17.9 million to regular profit and non regular expenses of $4.3

million to the Group.

22

For

per

sona

l use

onl

y

Page 24: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Associated Entities

Clover Corporation Limited – 28.6%

Year Ended 31 July 2013

Clover reported sales revenue of $44.1 million for the year ended 31 July 2013, an

increase of 14.9% over 2012.

Net profit after tax was $6.1 million an increase of 38.6%.

Clover has paid a fully franked final dividend of 1.5 cents per share bringing total

dividends for the year to 2 cents fully franked.

Clover contributed a net profit of $1.7 million to the Group.

23

For

per

sona

l use

onl

y

Page 25: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Associated Entities

TPG Telecom Limited – 26.9%

Year Ended 31 July 2013

TPG reported an EBITDA of $293.1 million for the year ended 31 July 2013, an increase of

12% over last year.

Net profit after tax for the year was $149.2 million, up 64%.

The 2012 result included a one-off tax expense of $23.2 million .

After excluding this from the results, 2013 represents a 31% increase in net profit.

Earnings per share increased to 18.8 cents per share.

24

For

per

sona

l use

onl

y

Page 26: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Associated Entities

TPG Telecom Limited – 26.9%

These graphs show TPG’s recent growth in

EBITDA,

normalised NPAT,

normalised EPS and

Dividends.

25

For

per

sona

l use

onl

y

Page 27: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Associated Entities

TPG Telecom Limited – 26.9%

The quality of TPG’s earnings result was again reflected in its cash flow performance.

$317.8 million cash was generated from operations before tax.

After tax, interest and capital expenditure, TPG had free cash flow of $174.5 million.

This free cash flow enabled TPG to repay $107 million of debt during the year, fund

investment and pay an increased dividend.

At year end net debt had been reduced to $16 million.

TPG declared a fully franked final dividend of 4 cents per share bringing total dividends for

the year to 7.5 cents, an increase of 36% over last year.

TPG contributed $40.2 million to Group profit.

26

For

per

sona

l use

onl

y

Page 28: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Associated Entities

Australian Pharmaceutical Industries – 24.6%

Ruralco Holdings Limited – 23.5%

API contributed $6.1 million to Group Profit and

Ruralco contributed $800,000 to Group Profit.

Both of these companies have released year end results since July which I will discuss

shortly.

27

For

per

sona

l use

onl

y

Page 29: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

28

Updates

I will now provide an update of the 2014 financial year.

Please note that other than API and Ruralco the following results are unaudited.

For

per

sona

l use

onl

y

Page 30: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

29

Parent Company Share Portfolio

As at the end of last month, the market value of WHSP’s listed investment portfolio was

$4.35 billion including controlled & associated entities up from $4.2 billion at the end of

July.

The market value, excluding controlled & associated entities, was $555 million up from

$521 million at July.

For

per

sona

l use

onl

y

Page 31: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

30

Parent Company Share Portfolio (continued)

The Company’s ten largest listed investments based on market value as at 30

November 2013, excluding controlled and associated entities were:- (see slide).

For

per

sona

l use

onl

y

Page 32: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

New Hope Corporation Limited

Outlook

New Hope’s coal assets remain well positioned to weather the current soft market

conditions.

Production and sales for 2014 are likely to be slightly lower due to the cessation of

mining at Oakleigh and the scaling back of operations at Jeebropilly.

Port operations are expected to achieve marginally increased exports in 2014.

Coal prices are forecast to remain weak in US Dollar terms over the coming twelve

months, however, the recent devaluation of the Australian Dollar has lifted the average

price in Australian Dollar terms.

New Hope’s strong balance sheet provides flexibility to take advantage of acquisition

opportunities.

31

For

per

sona

l use

onl

y

Page 33: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Controlled Entities

CopperChem Limited / Exco Resources Limited

Update

CopperChem has commenced mining at Exco’s Mount Colin mine three months ahead

of schedule.

Mount Colin is an open-cut mine located 60 kilometres east of Cloncurry.

Ore will be transported to CopperChem’s plant at Cloncurry for processing.

Mount Colin has a resource of 2.15 million tonnes at 2.38% copper and 0.4 parts per

million of gold.

The copper grade is looking very promising at lower levels.

The White Dam gold project in South Australia is being re-mined with production now at

20 ounces per day.

On a consolidated basis CopperChem/Exco expect to be EBITDA positive in the second

half of the 2014 financial year, leading to an overall positive EBITDA result for the full

year.

32

For

per

sona

l use

onl

y

Page 34: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Australian Logistics Property Fund

Update

The Erskine Park Project in Western Sydney is scheduled to reach Practical Completion

on Wednesday next week and the long term lease to Super Retail Group Limited will

commence at that time.

The Brendale project in Queensland will also to be leased to Super Retail Group.

Ground works are continuing and construction commenced on 13 November.

The Practical Completion target for the project is mid next year.

The market conditions for these long term, pre leased, developments are positive, with

the margin between cost of funding and the yields available remaining at historic highs.

These assets will provide simple and consistent cash flows to the Group.

33

For

per

sona

l use

onl

y

Page 35: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Australian Logistics Property Fund

Super Retail Group Limited facility at Erskine Park NSW 30 November 2013.

To give you a sense of the scale of these structures, this particular building is equivalent

to approximately 8 football fields.

34

For

per

sona

l use

onl

y

Page 36: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

35

Australian Pharmaceutical Industries Limited

Year Ended 31 August 2013

API released its results for the year ended 31 August 2013 on October 24.

Revenue for the year was $3.19 billion, down marginally on 2012, due to ongoing PBS

reforms.

API reported a net profit after tax of $24.3 million for the year, an increase of 9.6% after

allowing for insurance proceeds received in 2012.

API has declared a final dividend of 1.75 cents per share fully franked, bringing the total

dividend for the year to 3.25 cents fully franked, up 8.3% on last year.

For

per

sona

l use

onl

y

Page 37: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

36

BKI Investment Company Limited

Update

BKI’s Net Operating Result (excluding Special Dividend Income) for the quarter ended

September 2013 was up 10% on the first quarter last year.

During September and October, BKI successfully raised $107 million, at $1.48 per share,

through a Placement and a 1 for 15 Entitlement Offer.

The BKI Portfolio Valuation including cash and receivables was $864 million as at 31

October.

Barring any unforeseen circumstances, BKI is confident of at least maintaining the Interim

and Final Ordinary Dividends during the 2014 financial year.

For

per

sona

l use

onl

y

Page 38: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

37

Brickworks Limited

Update – Building Products

The profitability of Brickworks’ Building Products division has improved in the first

quarter of 2014 compared to the previous corresponding period, driven primarily by

increased contributions from Austral Bricks and Austral Masonry.

In both operations sales volumes and margins have increased over the prior

corresponding period.

Improved plant efficiency resulted in production costs being well contained, due to the

increased volumes and a range of operational improvements.

Bristile Roofing earnings have remained steady.

Austral Precast earnings were also steady.

Direct earnings comparison with the prior period is difficult for Auswest Timbers, as last

year was impacted by a fire that disrupted operations in Western Australia.

Future prospects remain encouraging, with orders in most regions and divisions being

comfortably ahead of sales.

For

per

sona

l use

onl

y

Page 39: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

38

Brickworks Limited

Outlook - Land and Development

The Brickworks Property Trust is currently seeing significant growth. Two developments

have already been completed during the first quarter.

One of these properties, an expansion project for Toll Holdings was sold during the first

quarter to our Joint Venture partner, the Goodman Australia Industrial Fund for cash

proceeds of $11.6 million, in line with the book value.

A further two developments are expected to be completed in the final quarter of the

current financial year.

The opening of the Erskine Park Link Road and the NSW Government’s commitment to

fund the upgrade of Old Wallgrove Road will also assist in continuing to open up the

Eastern Creek employment area and drive further growth in the medium and longer

term.

Additional potential transactions in 2014 financial year include:

• The sale of Rochedale into the Property Trust,

• The 12.2 hectare Riverview site currently on the market for lease or sale, and

• The Port Kembla site in New South Wales currently on the market for lease or sale.

For

per

sona

l use

onl

y

Page 40: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

39

Ruralco Holdings Limited

Year Ended 30 September 2013

Ruralco recently announced its results for the year ended 30 September 2013.

Compared to the prior year:

• Sales were $1.16 billion, up 2% and

• Net Profit after tax was $5.7 million, down 59%.

Ruralco has advised that the results were impacted by:

• Dry and hot conditions,

• Lower livestock commodity prices and

• Reduced 1st half crop protection and animal health sales.

The final dividend was maintained at 10 cents per share fully franked. For

per

sona

l use

onl

y

Page 41: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

40

TPG Telecom Limited

Outlook

TPG has provided EBITDA guidance for the 2014 financial year of between $290 million

and $300 million.

At its Annual General Meeting, earlier this week, TPG advised that:

• it is now in a net cash position, having repaid debt of $350 million since 2010, and

• that its FY2014 results were tracking well to budget.

IRU: Indefeasible right of use, of cable network. For

per

sona

l use

onl

y

Page 42: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

41

I will now review the structure of the group and the cross shareholding and update

shareholders on the recent proposal received from M.H. Carnegie & Co and Perpetual

Investment Management.

41

For

per

sona

l use

onl

y

Page 43: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Currently WHSP owns 44.3% of Brickworks and Brickworks owns 42.7% of WHSP.

This cross-shareholding structure has been in place for over 40 years and in that time

has served both companies extremely well – providing strength through all points of the

cycle.

As you may be aware, M.H. Carnegie & Co and Perpetual Investment Management

have requestioned meetings of both WHSP and Brickworks to vote on a transaction

primarily designed to break up the cross-shareholding.

The investment was made in 1969 – Brickworks was seeking stability from a diversified

investment to protect it from the volatility of building cycles and WHSP was seeking an

investment to add to its portfolio.

While this is a longstanding relationship, it does not necessarily mean that it is outdated.

The structure has delivered, and continues to deliver, solid returns to shareholders.

42

For

per

sona

l use

onl

y

Page 44: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

Recent analyst commentary supports the proposition that the cross shareholding has

delivered strong performance and a breakup of the structure could be detrimental to

value.

In April this year, Citi said: “We don’t see material upside to warrant a break up of

BKW’s marriage to SOL. Most conventional unwind options, from the perspective of

BKW, suffer from CGT leakage while other options are impractical or simply don’t offer

sufficient upside to merit a breakup.”

Adding that “SOL’s track record speaks for itself”.

And in September this year, RBS Morgans wrote: “We remain unconvinced that a

change to SOL’s structure will unlock value. Its track record suggests that its diverse

investments are core to its sustainability of earnings and investor returns. Indeed a

restructuring may lead to increased earnings volatility, risk and a subsequent decrease

in long term value.”

43

For

per

sona

l use

onl

y

Page 45: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

As you can see from the graph on this slide, since the formation of the cross

shareholding over 40 years ago, WHSP has performed extremely well delivering total

shareholder return of 14.1% per annum.

$1,000 invested in 1969 would today be worth over $355,000 if a shareholder had

reinvested all dividends and reflecting the large number of bonus shares issued over the

years.

This growth does not reflect the significant amount of franking credits paid over the years

since the dividend imputation system was introduced in 1987.

44

For

per

sona

l use

onl

y

Page 46: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

This graph shows WHSP’s performance against the All Ordinaries Accumulation Index

over the past 15 years to 22 October 2013 (the day prior to receipt of the proposal from

Carnegie and Perpetual).

Total shareholder return assumes that dividends received are reinvested into the stock

at the time of receipt.

Over this period, WHSP has generated total shareholder return of 14.7% per annum.

This compares with growth of 8.6% per annum of the All Ordinaries Accumulation Index

over the same period.

WHSP’s long term investment strategy has created outperformance of 6.1% per annum.

Over 15 years, the index has only increased by a multiple of 2.7 times compared to an

investment in WHSP increasing over 7.3 times.

45

For

per

sona

l use

onl

y

Page 47: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

This slide shows how dividends have grown significantly over the last 25 Years. The

dividends paid prior to June 2002 have been adjusted for the 10:1 Share Split.

It is clear from this chart that WHSP has an exceptional history of paying dividends to

shareholders and furthermore the Company has not missed paying a dividend since

listing in 1903.

The Company receives dividends from its investments and interest from funds on

deposit. This year total dividends paid totalled $110 million representing 76.6% of

ordinary dividends and interest received during the financial year.

46

For

per

sona

l use

onl

y

Page 48: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

This graph demonstrates the benefits of WHSP’s diverse portfolio which protects it

against short term volatility of individual investments.

Over 15 years WHSP’s market capitalisation has grown from $575m to $3.5 billion which

is represented by the blue area and referenced to the right hand axis.

The performance of a number of investments has contributed to this growth. A selection

of these companies has been indexed to 100 in 1998 and their growth measured on the

left hand axis. For example New Hope (represented by the black line) had outstanding

performance between 2007 and 2011 and TPG (shown by the red line) had very strong

performance through 2012 and 2013.

This graph represents share prices and market capitalisation only and therefore does

not capture the significant dividends, special dividends and franking credits paid over the

years.

47

For

per

sona

l use

onl

y

Page 49: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

48

On 23 October this year, Carnegie and Perpetual requestioned a general meeting of

WHSP to consider a number of resolutions. The requisition was given to the board

without notice and without any discussion in relation to the proposal. This proposal has

not been developed between the boards of WHSP and Brickworks, rather it has been

exclusively formulated by Carnegie and Perpetual.

The purpose of the meeting is to consider two transactions. Broadly these transactions

are:

1. The demerger of TPG which involves WHSP making an in-specie distribution of all

of its TPG shares to shareholders. The proposal will require WHSP to obtain

demerger relief from the ATO to avoid significant tax consequences to WHSP or its

shareholders as a result of the distribution.

2. A selective cancellation of all of the shares which Brickworks owns in WHSP.

WHSP will be required to effectively buy its own shares from Brickworks and cancel

those shares. Based on a complex formula created by Carnegie and Perpetual, the

indicative consideration payable by WHSP would be $250 million in cash and a

promissory note for $1.6 billion. That promissory note will be repayable by WHSP in

12 months and attract interest. The interest rate formulated by Carnegie and

Perpetual would potentially amount to $170 million for the year. The consideration

would be paid to Brickworks as a dividend and be franked to the full extent of

WHSP’s franking balance. This would transfer to Brickworks all of WHSP’s franking

credits.

For

per

sona

l use

onl

y

Page 50: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

49

WHSP is yet to receive its Independent Expert Report and as such has not yet fully considered the proposals nor

made any formal recommendation to WHSP shareholders. There are some features of the proposal as set out in the

materials provided by Perpetual and Carnegie which will require careful consideration.

If the proposal is implemented, WHSP will lose its strategic investment in TPG. TPG is one of WHSP’s recent

success stories and continues to be a very strong growth investment in the portfolio. TPG was acquired through a

merger with SP Telemedia in 2008 when the combined market capitalisation of the businesses was $277 million.

Today the market capitalisation of TPG is $3.4 billion.

WHSP’s portfolio would shrink by the value of WHSP’s shareholding in TPG which is currently worth approximately

$910 million and WHSP would lose the future earnings from TPG which contributed $40.2 million to the Group’s profit

in FY13.

Utilising the numbers from Carnegie and Perpetual’s expert report, WHSP will owe Brickworks more than $1.6 billion

which will be required to be repaid in 12 months as consideration for the share cancellation. This is a very large debt

against the reduced size of the portfolio following the TPG distribution. WHSP has always taken a prudent approach

to investing and has not traditionally had debt at the parent level. The cost of the debt, utilising the interest rates

indicated by Carnegie and Perpetual, could be as much as $170 million per annum.

The proposal requires WHSP to transfer all of its franking credits to Brickworks. This has not been valued by the

expert commissioned by Carnegie and Perpetual but is an asset of value to WHSP shareholders and is being given to

one shareholder at the expense of all other shareholders.

Finally, the proposal requires the payment of all of WHSP’s available cash to Brickworks such that WHSP will not

have cash to make further investments, pay dividends or to support its existing investments. This could impact the

value and growth options for a range of WHSP’s investments which may need cash to grow.

For

per

sona

l use

onl

y

Page 51: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

The proposal is highly complex and there are a number of uncertainties for WHSP and its shareholders.

The proposals have assumed that a number of favourable tax rulings will be provided by the Australian Tax Office in relation to

demerger relief for the TPG distribution and the franking of the consideration payable to Brickworks as part of the proposal. There

is no certainty that these rulings will be provided in the manner expected by Carnegie and Perpetual and the effect the transaction

will have on shareholders of both WHSP and Brickworks is unknown at this stage. There is a risk that implementation of the

proposal could result in unfavourable tax consequences.

Carnegie and Perpetual have also requisitioned a general meeting of Brickworks which will be held on 28 February 2014 to

consider the proposals. Brickworks is seeking guidance from the ASX as to whether WHSP can vote at that meeting. The

determination made by the ASX will likely have a bearing on the voting eligibility at the WHSP meeting. To date, the ASX has not

provided its decision in relation to this matter.

If the proposal was implemented in its current form, Perpetual and Carnegie’s joint holding in WHSP would increase to

approximately 22%. They will have moved to this position of influence without disclosing their intentions in relation to the future of

WHSP.

Another risk inherent in the formula created by Perpetual and Carnegie is that WHSP shareholders are taking significant market

risk. The complex formula to calculate the consideration paid to Brickworks has a floor price of $15.75 which means that WHSP is

still required to pay $15.75 even if the formula calculates a lower amount.

While WHSP has the large $1.6 billion debt, it would need to pay over $170 million of interest and be in a position to repay the debt.

It would therefore be unlikely that WHSP would pay a dividend while it has this debt obligation. The lack of franking credits could

also curtail future dividends.

The requirement for WHSP to take on $1.6 billion of debt as part of this proposal creates uncertainty as it is not clear how this debt

would be repaid. Some of the suggestions made by Carnegie/Perpetual involve Brickworks agreeing to do something to assist

WHSP with the repayment of the debt. Given the debt is owed to Brickworks, Brickworks will have significant bargaining power

which creates risk to WHSP. It was also suggested that the debt could be refinanced by a bank. We believe this is an

irresponsible level of debt, particularly given the reduced size of the portfolio after the TPG demerger and it is unlikely that the

assets could support that level of debt. The only option to repay the debt which is within the control of WHSP is to liquidate its

assets. This means New Hope would need to be sold which would be unlikely to realise full market value and would trigger a

significant capital gains tax expense.

50

For

per

sona

l use

onl

y

Page 52: ASX Announcement - 6 December 2013 For personal use only · 2020. 5. 28. · Apex Healthcare Berhad – 30.3% Half Year Ended 30 June 2013 Apex Healthcare Berhad is a manufacturer,

The proposal is a major transaction involving WHSP and consequently the Board is

carefully assessing all aspects of the transaction.

The Board has appointed an Independent Expert to provide an opinion to WHSP

shareholders on the merits of the transactions and whether the proposal is fair and

reasonable. This report will be included with the Notice of Meeting and accompanying

Explanatory Statement to be sent to shareholders.

The materials for the requisitioned meeting will be sent to shareholders prior to 24

January 2014 so that shareholders can consider the resolutions to be put at the meeting

which will be held on or before 28 February 2014.

The company is engaging with the ATO to provide some guidance on the rulings

required to be given in relation to the proposals. The Board considers it is fundamental

for shareholders to understand the potential tax implications in relation to the proposal

before voting on the resolutions. The board will endeavour to have further information

on the taxation consequences prior to the meeting.

As discussed on the previous slide, WHSP is waiting for a decision from the ASX on

who can vote at the Brickworks meeting. WHSP does not believe it should be excluded

from voting on a transaction that it has not been involved in formulating and which has

such an important bearing on the future of the company and its shareholders.

At this stage, shareholders are not required to take any action and the Board has not yet

provided a formal recommendation to the shareholders of WHSP. The Board urges

shareholders to read the notice of meeting and accompanying materials when it is

received. If there are any questions, please contact the shareholder information line

which will be set up once the materials have been sent out. 51

For

per

sona

l use

onl

y